The administration of a recombinant soluble form of RAGE (sRAGE) consisting of its extracellular ligand-binding domain has recently been shown to not only suppress the development of atherosclerosis but also to stabilize established atherosclerosis in diabetic apolipoprotein E-null mice [86, 87]. The gene discussed is AGER; the disease is atherosclerosis.